Online first
Letter to the Editor
Published online: 2024-06-13
Reassessment of the underlying mechanisms that contribute to the neurological disorders linked to long-term COVID-19
DOI: 10.5603/demj.100529
Abstract
Not available
Keywords: COVID-19long COVID-19neurological
References
- Graban M, Pruc M, Chirico F, et al. Neurological implications of LONG-COVID-19 — current knowledge and the need for implementing remedies. Disaster Emerg Med J. 2024; 9(1): 60–61.
- Hampshire A, Azor A, Atchison C, et al. Cognition and memory after COVID-19 in a large community sample. N Engl J Med. 2024; 390(9): 806–818.
- Petersen M, Nägele FL, Mayer C, et al. Brain imaging and neuropsychological assessment of individuals recovered from a mild to moderate SARS-CoV-2 infection. Proc Natl Acad Sci U S A. 2023; 120(22): e2217232120.
- Greene C, Connolly R, Brennan D, et al. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024; 27(3): 421–432 Erratum in: Nat Neurosci. 2024 Apr 16.
- Wong AC, Devason AS, Umana IC, et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023; 186(22): 4851–4867.e20.
- Dziedzic K, Pruc M, Kilic M, et al. Sex- and gender-specific differences in the inflammatory response to COVID-19: the role of the neutrophil-to-lymphocyte ratio. Disaster Emerg Med J. 2023; 8(4): 234–242.
- Harris E. Long COVID linked with viral persistence, serotonin decline. JAMA. 2023; 330(19): 1827.
- Dziedzic K, Rahnama-Hezavah M, Tomaszewska M, et al. Breaking down the clotting conundrum: analyzing the role of plasma tissue plasminogen activator in COVID-19 patients through a systematic review and meta-analysis. Disaster Emerg Med J. 2023; 8(4): 207–215.